$51M sweet spot round size
Most of their 19 investments are in rounds between $41M and $81M
2018
OMass Therapeutics raised $13M on May 15, 2023
Investors: British Patient Capital
Quantexa raised $129M on April 3, 2023
Investors: Evolution Equity Partners, Warburg Pincus LLC, AlbionVC, BNY Mellon, GIC, Dawn Capital, ABN AMRO Ventures and British Patient Capital
CyberSmart raised $15M on February 23, 2023
Investors: Legal & General Capital, -, Oxx, Solano Partners, WINTON VENTURES LIMITED, Seedcamp, IQ Capital and British Patient Capital
Quantum Motion Technologies raised $51M on February 21, 2023
Investors: Oxford Sciences Innovation, Inkef, Robert Bosch Venture Capital GmbH (RBVC), IP Group plc, Parkwalk Advisors, Octopus Ventures, Porsche Automobil Holding SE and British Patient Capital
Grey Wolf Therapeutics raised $49M on January 26, 2023
Investors: Oxford Sciences Innovation, Earlybird Venture Capital, Canaan, Andera Partners and British Patient Capital
Perspectum Ltd raised $37M on January 5, 2023
Investors: The Blue Venture Fund, HealthQuest Capital and British Patient Capital
PragmatIC raised $35M on December 14, 2022
Investors: Prosperity7 Ventures and British Patient Capital
Nucleome Therapeutics raised $42M on October 19, 2022
Investors: Oxford Sciences Innovation, M Ventures and British Patient Capital
Oxford Quantum Circuits raised $46M on July 5, 2022
Investors: Oxford Sciences Innovation, Oxford Investment Consultants LLP, Lansdowne Partners and British Patient Capital
CloudNC raised $45M on June 21, 2022
Investors: Episode 1 Ventures, Atomico and British Patient Capital